Tested Applications
Positive WB detected in | A431 cells, MCF-7 cells, T-47D cells |
Positive IF/ICC detected in | A431 cells |
Recommended dilution
Application | Dilution |
---|---|
Western Blot (WB) | WB : 1:2000-1:12000 |
Immunofluorescence (IF)/ICC | IF/ICC : 1:200-1:800 |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, Check data in validation data gallery. |
Product Information
13671-1-AP targets GALNT6 in WB, IF/ICC, ELISA applications and shows reactivity with human samples.
Tested Reactivity | human |
Host / Isotype | Rabbit / IgG |
Class | Polyclonal |
Type | Antibody |
Immunogen | GALNT6 fusion protein Ag4652 Predict reactive species |
Full Name | UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 6 (GalNAc-T6) |
Calculated Molecular Weight | 622 aa, 71 kDa |
Observed Molecular Weight | 71 kDa |
GenBank Accession Number | BC035822 |
Gene Symbol | GALNT6 |
Gene ID (NCBI) | 11226 |
RRID | AB_3669168 |
Conjugate | Unconjugated |
Form | Liquid |
Purification Method | Antigen affinity purification |
UNIPROT ID | Q8NCL4 |
Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol , pH 7.3 |
Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Background Information
GALNT6 (polypeptide N-acetylgalactosaminyltransferase 6, GalNAc-T6), which is involved in the initiation of O-glycosylation, has been reported to play crucial roles in mammary carcinogenesis through binding to several substrates (PMID: 32393740). GALNT6 is upregulated in breast, ovarian, renal cell, lung and pancreatic cancers (PMID: 20215525). Overexpression of GRP78 could enhance Golgi-to-ER relocation of GALNT6 (PMID: 28110670).
Protocols
Product Specific Protocols | |
---|---|
WB protocol for GALNT6 antibody 13671-1-AP | Download protocol |
IF protocol for GALNT6 antibody 13671-1-AP | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |